Sheng, Jiyao <br/><br/>
Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial-lysosomal crosstalk.  [electronic resource] 

 -  Cell proliferation  May 2019 
 - e12609 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2184 
<br/><br/><label>Standard No.: </label>10.1111/cpr.12609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Lysosomes--drug effects<br/>Mitochondria--drug effects<br/>Mitochondrial Dynamics--drug effects<br/>Mitophagy--drug effects<br/>Phenylurea Compounds--pharmacology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Pyrimidines--pharmacology<br/>Reactive Oxygen Species--metabolism<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors